Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings (XTNT)
:XTNT
Holding XTNT?
Track your performance easily
Earnings Data
Report Date
Mar 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.03Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 14, 2018
|% Change Since: -3.70%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful new product launches, along with strategic initiatives to improve operational efficiency and profitability through in-house manufacturing. However, challenges such as product launch delays, decreased gross margins, and a net loss were also noted. Despite these lowlights, the positive trends and strategic initiatives suggest a cautiously optimistic outlook.Company Guidance
During the Xtant Medical Holdings Q3 2024 earnings call, the company provided guidance for the full year revenue to be within the range of $116 million to $120 million, indicating an annual growth rate of approximately 27% to 31% compared to 2023. The company reported a 12% revenue growth for the quarter and 36% growth year-to-date, despite some product launch delays. The adjusted EBITDA for Q3 was a loss of $193,000, with year-to-date profitability at $435,000 on an adjusted EBITDA basis. The company also highlighted a significant licensing agreement in the advanced wound care market, which included an upfront payment of $1.5 million and projected minimum revenues of $3.75 million in 2025. They anticipate achieving positive adjusted EBITDA in Q4 2024 as they continue to focus on profitability and operational efficiency, reducing operating expenses and leveraging recent acquisitions.Strong Revenue Growth
Achieved 12% growth for the quarter and 36% growth year-to-date. Expected to achieve full year revenue guidance of $116 million to $120 million, representing a total annual revenue growth of approximately 27% to 31% compared to 2023.
Successful Product Launches
Overcame challenges to launch OsteoVive Plus and Cortera products, which are well received by distributors and surgeons, bolstering confidence in strong fiscal year-end performance.
Licensing Agreement with Advanced Wound Care Market
Signed a licensing agreement resulting in a $1.5 million upfront payment and expected minimum revenue of $3.75 million in 2025.
Operational Efficiency and Cost Management
Operating expenses were lower compared to the three preceding quarters, demonstrating improved cost management and efficiency.
In-house Manufacturing Strategy
Focused on bringing manufacturing in-house to control supply chain and improve gross margins from mid-40s to 60% to the mid-80% to low 90% range.
---
XTNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
XTNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $0.54 | $0.47 | -12.96% |
| Aug 08, 2024 | $0.65 | $0.65 | 0.00% |
| May 15, 2024 | $0.79 | $0.69 | -12.66% |
| Apr 01, 2024 | $1.17 | $1.03 | -11.97% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Xtant Medical Holdings (XTNT) report earnings?
Xtant Medical Holdings (XTNT) is schdueled to report earning on Mar 11, 2025, TBA Not Confirmed.
What is Xtant Medical Holdings (XTNT) earnings time?
Xtant Medical Holdings (XTNT) earnings time is at Mar 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is XTNT EPS forecast?
XTNT EPS forecast for the fiscal quarter 2024 (Q4) is -0.01.
---